| Particulars |
|
|
|
| Company Name
| Procter & Gamble Health Ltd
| Year End
| 202406
|
| Full Year |
| Equity (₹ Cr.) |
16.60 |
B.V. (₹) |
367.80 |
| Sales(₹ Cr.) |
1,151.26 |
NP (₹ Cr.) |
215.69 |
| NP Var% |
-6.00 |
Div% |
2,600.00 |
| CPS(₹) |
146.40 |
EPS (₹) |
129.90 |
| Traded Value(₹ Lakhs) |
19.45 |
52 Week High |
5,836.00 |
| 52 Week Low |
4,640.00 |
Price BSE |
5,259.00 |
| Price NSE |
5,257.00 |
Market Capital (₹ Cr.) |
8,730.20 |
| P/C Ratio |
35.90 |
P/E Ratio |
40.50 |
| Price Vs.BV |
14.30 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
309.77 |
| NP(₹ Cr.) |
90.90 |
NP Var % |
26.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
1,159.74 |
| OPM |
28.57 |
NP |
226.62 |
| NP Var% |
8.29 |
EPS |
147.87 |
| PE |
35.57 |
|
|